International law firm McDermott Will & Schulte represented Tarrytown Expocare Pharmacy (Tarrytown) and Sheridan Capital Partners (Sheridan) in connection with the sale of Tarrytown to funds managed by Carlyle (NASDAQ: CG). Sheridan will retain a minority ownership position.

Tarrytown is a closed-door, long-term care pharmacy dedicated exclusively to serving the intellectual and developmental disability and behavioral health communities. McDermott represented Sheridan in its initial investment in Tarrytown in 2019 and continued to advise Sheridan and Tarrytown throughout Sheridan’s ownership period, during which Tarrytown expanded its geographic footprint, completed multiple add-on acquisitions, and significantly scaled its operations and service offerings.

The McDermott team was led by Dana Dombey, Bernie Grondin, James Parry, and Cornelia Dean with invaluable assistance from Jun Won Kim, Chelsea Rogers, Michael Nowicki, Greg Berson, Andrea Zazulia, Sarah Kitchell, Chelsea Olivera, Josh Neumann, Lara Kimmel, Dane Chapman, Tyler Barton, Grayson Dimick, Joshua Samis, John Parker, Nicole Briody, Alex Ruiz, John Zhang, Jeff Holdvogt, Jennifer Hill, Abigail Kagan, Joe Anderson, Greg Heltzer, Ty Carson, Sam Siegfried, Sarah Bro, and Zuri Bello.

This transaction highlights McDermott’s strength in advising healthcare clients and private equity sponsors on complex, cross-sector transactions in the long-term care and pharmacy services industries.

Read Carlyle’s press release here.

Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,750+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.